LAURUSLABS.BO
Price:
$1025.95
Market Cap:
$553.95B
Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C therapeutic areas. It also develops and manufactures oral solid formulations for ARVs, anti-diabetic, cardiovascular, PPIs, and central nervous system. In addition, the company provides contract development and manufacturing services for pharmaceutical companies; and manufactures and sells specialt...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2016-12-19
Stock Exchange
BSE
Ticker
LAURUSLABS.BO
According to Laurus Labs Limited’s latest financial reports and current stock price. The company's current PE Ratio is 81.30. This represents a change of 34.95% compared to the average of 60.24 of the last 4 quarters.
The mean historical PE Ratio of Laurus Labs Limited over the last ten years is 45.60. The current 81.30 PE Ratio has changed 17.73% with respect to the historical average. Over the past ten years (40 quarters), LAURUSLABS.BO's PE Ratio was at its highest in in the June 2024 quarter at 468.26. The PE Ratio was at its lowest in in the January 2016 quarter at 0.
Average
45.60
Median
33.81
Minimum
13.57
Maximum
136.45
Discovering the peaks and valleys of Laurus Labs Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 581.89%
Maximum Annual PE Ratio = 136.45
Minimum Annual Increase = -69.85%
Minimum Annual PE Ratio = 13.57
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 90.20 | -33.90% |
| 2024 | 136.45 | 581.89% |
| 2023 | 20.01 | -47.95% |
| 2022 | 38.44 | 94.13% |
| 2021 | 19.80 | 45.89% |
| 2020 | 13.57 | -69.85% |
| 2019 | 45.02 | 39.51% |
| 2018 | 32.27 | 29.90% |
| 2017 | 24.84 | -29.73% |
| 2016 | 35.35 | -43.28% |
The current PE Ratio of Laurus Labs Limited (LAURUSLABS.BO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
82.22
5-year avg
60.98
10-year avg
45.60
Laurus Labs Limited’s PE Ratio is greater than Glenmark Pharmaceuticals Limited (73.73), greater than Glenmark Pharmaceuticals Limited (73.73), greater than Aurobindo Pharma Limited (20.66), less than Biocon Limited (103.54), greater than Alkem Laboratories Limited (28.74), less than Biocon Limited (103.54), greater than Alkem Laboratories Limited (28.74), greater than GlaxoSmithKline Pharmaceuticals Limited (45.14), greater than Aurobindo Pharma Limited (20.66), greater than GlaxoSmithKline Pharmaceuticals Limited (45.14),
| Company | PE Ratio | Market cap |
|---|---|---|
| 73.73 | $555.43B | |
| 73.73 | $554.74B | |
| 20.66 | $707.18B | |
| 103.54 | $524.42B | |
| 28.74 | $678.59B | |
| 103.54 | $524.22B | |
| 28.74 | $680.24B | |
| 45.14 | $430.81B | |
| 20.66 | $707.10B | |
| 45.14 | $431.24B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Laurus Labs Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Laurus Labs Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Laurus Labs Limited's PE Ratio?
How is the PE Ratio calculated for Laurus Labs Limited (LAURUSLABS.BO)?
What is the highest PE Ratio for Laurus Labs Limited (LAURUSLABS.BO)?
What is the 3-year average PE Ratio for Laurus Labs Limited (LAURUSLABS.BO)?
What is the 5-year average PE Ratio for Laurus Labs Limited (LAURUSLABS.BO)?
How does the current PE Ratio for Laurus Labs Limited (LAURUSLABS.BO) compare to its historical average?